The enduring material is jointly provided by William Beaumont Hospital, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).
The 10th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 28-30, 2016 in Dallas, TX. The Conference was supported by funding from the Clinical Education Initiative, New York State Department of Health, AIDS Institute; and from the HIV Medicine Association (HIVMA). The conference and this web archive were supported by educational grants from Bristol-Myers Squibb; Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare.
ONLINE CE CREDIT:
H. Nina Kim, MD, MSc, is an Associate Professor of Medicine and Adjunct Associate Professor of Global Health at the University of Washington (UW). She is the Director of the Madison HIV/Hepatitis Coinfection Clinic at Harborview Medical Center in Seattle.
Estimated time to complete: 30 minutes
Physicians (both specialists and primary care/family medicine), nurse practitioners, and nurses who are frontline providers of care to persons at risk of or with HIV infection. Physician assistants, pharmacists, case managers and other healthcare professionals may also participate.
As a result of participating in this activity, participants should be better able to:
- Select appropriate DAA therapy in HIV-HCV coinfected patients.
- Discuss some real-world HCV treatment issues related to choice of direct-acting antiviral (DAA) therapy in HIV-HCV coinfected patients
- Identify relevant drug interactions with DAAs and antiretroviral therapy
- Recognize some important adverse events of currently available DAAs
- Highlight the potential for HCV reinfection after treatment clearance
H. Nina Kim, MD, MSc – no relevant financial relationships to disclose.
For CME information or credit details, contact: firstname.lastname@example.org
For CNE information or credit details, contact: CEservices@academycme.org
H. Nina Kim, MD, MSc
Associate Professor of Science
University of Washington
Dr. Nina Kim is an Associate Professor of Medicine and Adjunct Associate Professor of Global Health at the University of Washington (UW). She is the Director of the Madison HIV/Hepatitis Coinfection Clinic at Harborview